BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8256164)

  • 1. [Plasma coagulation and fibrinolysis parameters in patients with vascular Behçet's disease, and analysis of the multimeric structure of von Willebrand factor (vWF)].
    Kagawa H; Okubo S
    Ryumachi; 1993 Oct; 33(5):416-23. PubMed ID: 8256164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma coagulation and fibrinolysis parameters in patients with collagen diseases, and analysis of the multimeric structure of von Willebrand factor (vWF).
    Kagawa H; Okubo S; Yasunaga K
    Int J Hematol; 1991 Oct; 54(5):429-39. PubMed ID: 1756253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Von Willebrand factor in Behçet's syndrome.
    Yazici H; Hekim N; Ozbakir F; Yurdakul S; Tüzün Y; Pazarli H; Müftüoğlu A
    J Rheumatol; 1987 Apr; 14(2):305-6. PubMed ID: 3496454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is Behçet's disease associated with characteristic abnormalities of coagulation and fibrinolysis? Apropos of 70 case reports].
    Conard J; Horellou MH; Wechsler B; Fassin D; Bletry O; Godeau P; Samama M
    J Mal Vasc; 1988; 13(3):257-61. PubMed ID: 3171405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation and fibrinolytic activity in Behçet's disease.
    Hampton KK; Chamberlain MA; Menon DK; Davies JA
    Thromb Haemost; 1991 Sep; 66(3):292-4. PubMed ID: 1745999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood coagulation and fibrinolysis in patients with Behçet's disease].
    Fusegawa H; Ichikawa Y; Tanaka Y; Miyachi Y; Kawada T; Gondo K; Ikeda M; Shimizu H; Arimori S; Ando Y
    Rinsho Byori; 1991 May; 39(5):509-16. PubMed ID: 2072574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased fibrinolysis in Behçet's disease.
    Chajek T; Aronowski E; Izak G
    Thromb Diath Haemorrh; 1973 Jun; 29(3):610-8. PubMed ID: 4761829
    [No Abstract]   [Full Text] [Related]  

  • 8. [Blood coagulation and fibrinolytic system in Behçet's disease (author's transl)].
    Hamada T; Hosoi Y; Yoshimura R; Yamamoto S
    Nihon Hifuka Gakkai Zasshi; 1978 Sep; 88(10):615-25. PubMed ID: 309522
    [No Abstract]   [Full Text] [Related]  

  • 9. Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behçet's disease--a multicenter study. The Behcet's Disease Research Committee of Japan.
    J Rheumatol; 1989 Apr; 16(4):506-11. PubMed ID: 2664172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The functioning of the fibrinolytic system in Behçet's syndrome].
    Asbeck F; Meyer-Boernecke D; van de Loo J
    Verh Dtsch Ges Inn Med; 1978; (84):1359-62. PubMed ID: 741967
    [No Abstract]   [Full Text] [Related]  

  • 11. Behçet's disease and streptococcal infection.
    Namba K; Ueno T; Okita M
    Jpn J Ophthalmol; 1986; 30(4):385-401. PubMed ID: 3586405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet function, blood coagulation and fibrinolysis in Behcet's syndrome.
    Stathakis NE; Economopoulos TC; Papayannis AG; Thomopoulos D
    Blut; 1977 Mar; 34(3):215-22. PubMed ID: 843627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Behçet's disease--analysis of 20 patients].
    Mitrović D; Krstić S; Ivković L; Mićić R; Lilić D; Dujić A
    Srp Arh Celok Lek; 1985; 113(5-6):443-56. PubMed ID: 4089677
    [No Abstract]   [Full Text] [Related]  

  • 14. [Behçet's disease: a vascular function study by the venostasis test and DDAVP infusion].
    Le Roux G; Guillevin L; Casassus P; Gayraud M; Limon S
    Rev Med Interne; 1985 Mar; 6(2):111-5. PubMed ID: 3923585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The relationship of the HLA antigen system to Behçet's disease].
    Golosenko IIu
    Vestn Dermatol Venerol; 1990; (5):55-7. PubMed ID: 2402945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High HL-A5 frequency in Behçet's disease.
    Nakayama E; Itakura K; Aizawa M
    Hokkaido Igaku Zasshi; 1976 Mar; 51(2):117-21. PubMed ID: 945222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The blood coagulation system in progressive systemic scleroderma].
    Sica S; Paoletti S; Storti S; Pagano L; Marra R; Garcovich A
    Minerva Med; 1987 Dec; 78(24):1831-4. PubMed ID: 2448705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte gamma-glutamyl transferase activity in Behçet's disease.
    Pabuçcuoğlu A; Karan A; Andaç K; Yağci A
    Arch Immunol Ther Exp (Warsz); 1989; 37(1-2):121-5. PubMed ID: 2575892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinopeptide A and fibrinopeptide B beta 15-42 in patients with Behçet's disease.
    Sunakawa M; Okinami S
    Metab Pediatr Syst Ophthalmol (1985); 1988; 11(4):147-8. PubMed ID: 3221795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Behçet's disease and lupus anticoagulant].
    Torrelo Fernández A; España Alonso A; Medina Montalvo S; Ledo Pozueta A
    Rev Clin Esp; 1990; 187(3):153. PubMed ID: 2126636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.